Search research articles
Contact Us
Filters
Showing results (201-210 of 222) with videos related to
Page
of 23
Sort By:
The Journal of Urology
|
September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer
Alberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
Surgical Endoscopy
|
December 6, 2018
The use of 3D laparoscopic imaging systems in surgery: EAES consensus development conference 2018
Alberto Arezzo, Nereo Vettoretto, Nader K Francis, et al.
European Urology Oncology
|
October 16, 2023
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study
Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al.
Frontiers in Oncology
|
April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
World Journal of Urology
|
October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
European Urology Oncology
|
December 27, 2023
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer
Finbar Slevin, Fabio Zattoni, Enrico Checcucci, et al.
World Journal of Urology
|
November 18, 2024
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
World Journal of Urology
|
November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
Margaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
Minerva Urology and Nephrology
|
April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Minerva Urology and Nephrology
|
April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry
Mariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 222) with videos related to
Sort By:
Page
of 23
The Journal of Urology
|
September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer
Alberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
Surgical Endoscopy
|
December 6, 2018
The use of 3D laparoscopic imaging systems in surgery: EAES consensus development conference 2018
Alberto Arezzo, Nereo Vettoretto, Nader K Francis, et al.
European Urology Oncology
|
October 16, 2023
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study
Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al.
Frontiers in Oncology
|
April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
World Journal of Urology
|
October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
European Urology Oncology
|
December 27, 2023
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer
Finbar Slevin, Fabio Zattoni, Enrico Checcucci, et al.
World Journal of Urology
|
November 18, 2024
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Gabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
World Journal of Urology
|
November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
Margaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
Minerva Urology and Nephrology
|
April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Minerva Urology and Nephrology
|
April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry
Mariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
Page
of 23